ADDISON, TX, August 26, 2013 -- HASCO Medical, Inc. (OTCQB: HASC), www.HascoMed.com, a Company that conducts sales of handicap accessible vans, parts, service and rental operations in sixteen locations from Maine to Florida and sales of medical equipment and supplies in Florida announced today their new Chief Financial Officer.
Prior to joining HASCO Medical, Inc. Mr. Mielke served as audit partner with Deloitte & Touche LLP in Dallas where his clients included both Fortune 500 and smaller private companies. He has served manufacturing and multi-location companies and has significant experience with financial reporting, public/private debt and equity offerings and due diligence. He previously held the position of senior financial reporting analyst with PepsiCo, Inc. as well as other positions with Deloitte & Touche.
Mr. Mielke holds a Master of Business Administration and Bachelor of Business Administration in accounting from Southern Methodist University in Dallas, Texas. He has been a Certified Public Accountant in Texas since 1991.
“I am very excited about Jens joining the HASCO Team. With Jens background and experience he should help move the company to a whole new level. This is such an exciting time for the HASCO family of companies because we have experienced such phenomenal growth over the last two years and now with another acquisition on the horizon Jens will help us look at new ways to continue our growth.” says Hal Compton, CEO of HASCO Medical, Inc.
About HASCO Medical, Inc.
HASCO Medical (www.HascoMed.com) provides products and services that dramatically improve the quality of living for its customers. The Company consists of Ride-Away (www.Ride-Away.com), Mobility Freedom (www.MobilityFreedom.com) and Wheelchair Vans of America (www.wcvans.com) on the Van Conversion/Rental side of the company and Southern Medical and Mobility, Inc. (discontinued operation) and Certified Medical on the durable medical equipment side.
HASCO Medical, Inc.
15928 Midway Rd.
Addison, TX. 75001
This press release may contain forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In some cases you can identify those so-called "forward looking statements" by words such as "may," "will," "should," "expects," "plans," "targets," "believes," "anticipates," "estimates," "predicts," "potential," or "continue" or the negative of those words and other comparable words. These forward looking statements are subject to risks and uncertainties, product tests, commercialization risks, availability of financing and results of financing efforts that could cause actual results to differ materially from historical results or those anticipated. Further information regarding these and other risks is described from time to time in the Company's filings with the SEC, which are available on its website at: http://www.sec.gov. We assume no obligation to update or alter our forward-looking statements made in this release or in any periodic report filed by us under the Securities Exchange Act of 1934 or any other document, whether as a result of new information, future events or otherwise, except as otherwise required by applicable federal securities laws.
SOURCE HASCO Medical, Inc.